According to the research report titled ‘Global Human Microbiome Market - Analysis By Product, By Disease, Application, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2019-2024)’, available with Market Study Report, global human microbiome market was worth USD 351.81 million in 2018 and is expected to record considerable growth over 2019-2024.
 

Escalating cases of diabetes, increasing research & development activities directed by pharmaceuticals manufacturers and academia, and rising geriatric population are some of the key factors driving the growth of global human microbiome market. Additionally, increasing cases of other chronic diseases and sedentary lifestyle are projected to contribute to the market expansion over the anticipated timeline. The growth in global human microbiome market can also be credited to market players in the industry collaborating with academia for data generation and treatment of diseases including issues with gut, which can be managed with the assistance of microbiota.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2473271/
 

Based on diseases, the global human microbiome market is divided into gastrointestinal disorder, autoimmune disorder, cancer, diabetes, obesity, and others. As per the product type, the market is split into medical foods, prebiotics, probiotics, and other. Probiotics segment currently holds a major share in global human microbiome market pertaining to the benefits it offers in gut microbiota and well-being of the patient.
 

From the regional point of view, global human microbiome market is fragmented into Asia Pacific, Europe, North America, and Rest of the World. North America is likely to lead the market in terms of share owing to supportive government reimbursement policies, in consort with high cognizance of healthcare in the region.
 

Brazil, China, and India are some of the countries that are a lucrative market for global human microbiome market.
 

Assembly Bioscience Inc., Ritter Pharmaceuticals, Rebiotix Inc., BaseClear BV, Synlogic Inc., 4D Pharma, PureTech Health, OSEL Inc., Metabiomics, and OptiBiotix Health Plc are some of the major players in global human microbiome market.